1. Home
  2. MLEC vs PULM Comparison

MLEC vs PULM Comparison

Compare MLEC & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

N/A

Current Price

$1.49

Market Cap

5.0M

Sector

Finance

ML Signal

N/A

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

N/A

Current Price

$1.31

Market Cap

5.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MLEC
PULM
Founded
2008
2003
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
5.2M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
MLEC
PULM
Price
$1.49
$1.31
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 75.0K
18.6K
Earning Date
12-15-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 46.18
EPS
★ N/A
N/A
Revenue
N/A
★ $7,910,000.00
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
$67.27
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 5069.93
52 Week Low
$0.21
$1.16
52 Week High
$23.22
$4.98

Technical Indicators

Market Signals
Indicator
MLEC
PULM
Relative Strength Index (RSI) 20.87 44.27
Support Level N/A $1.21
Resistance Level $9.27 $1.46
Average True Range (ATR) 0.35 0.11
MACD 0.07 0.00
Stochastic Oscillator 11.27 25.87

Price Performance

Historical Comparison
MLEC
PULM

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: